# OnCo record utc-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/utc-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "utc-therapeutics" ;
  schema:name "UTC Therapeutics"@en ;
  schema:alternateName "UTC Therapeutics Inc."@en ;
  schema:description "UTC Therapeutics develops CAR-T cell therapies for solid tumours, made from the patient's own immune cells and engineered to keep working inside the tumour. It is testing them in cancers that carry the markers mesothelin, HER2 or CD70."@en ;
  schema:url <https://onco.cc/companies/utc-therapeutics/>, <https://www.utctherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.utctherapeutics.com/>, <https://www.utctherapeutics.com/Overview/index.aspx>, <https://clinicaltrials.gov/study/NCT06256055>, <https://clinicaltrials.gov/study/NCT06658951>, <https://clinicaltrials.gov/study/NCT07500805> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/armored-car/>, <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/mesothelin/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cd70/>, <https://onco.cc/targets/gpc3/> .